New trial will send drug to COVID-19 patients' home to see if it can prevent serious complications
A new international clinical trial will examine if colchicine, a drug most often used to treat gout, can can reduce rates of hospitalization and death caused by the novel coronavirus.
No comments:
Post a Comment